NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/14/2025
Back to search
Official data from USPTO
DUOSPORE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
11/15/2025
Trademark type
Word
Nice classes
5
Filing date
12/29/2022
Registration date
07/16/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/16/2024
Last transaction
11/15/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
01
Owner location
BE
Examiner
BLANE, SUZANNE
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
R. D. (pessoa física)
Representatives
Timothy C. Bradley Carlson, Gaskey & Olds, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and veterinary preparations for medical or dietetic purposespreparations for treating infectious diseasesviral infectionsbacterial infectionsyeast infectionsfor treating cancerfor treating metabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases or conditions; pharmaceutical drugs for medical or dietetic purposesnamely for treating infectious diseasesviral infectionsbacterial infectionsyeast infectionsfor treating cancerfor treating metabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases or conditions; homeopathic preparations for use in the treatment of infectious diseasesviral infectionsbacterial infectionsyeast infectionsfor treating cancerfor treating metabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases or conditions; foodstuffs for medical purposesdietetic animal foodstuffs for medical purposes; dietetic foodstuffs for medical purposesnamely dietetic foods adapted for medical use; dietetic substances in the nature of confectionery substances adapted for medical purposes; food additives based on plant extracts for medical purposes; dietary food supplements for medical or dietetic purposes; dietary fiber for use as an ingredient for medical purposes; active pharmaceutical ingredients for medical purposesnamely drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; enzymessugarsvitaminsvitamin preparationsminerals and mineral preparations for medical purposes; vitamin tablets; vitamin drops; gummy vitamins; effervescent vitamin tablets; fortifying medicated beveragesbeverages with added vitamins for medical purposes; fortifying dietetic beveragesdietetic beverages with added vitamins for medical purposes; medicinal herbs and medicinal herb-based drinks; food supplements; pharmaceutical agents affecting metabolism; health food supplements for persons with special dietary requirements; pharmaceutical preparations for the prevention of diseases; nutraceuticals for use as a dietary supplement; infant formula; medical plasters; gauze materials for dressing; teeth filling material and dental wax; disinfectants; preparations for destroying noxious animals; fungicides and herbicides; sanitary preparations for medical use; dietetic substances adapted for medical use
Publications
History of USPTO decisions and trademark events.
32 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/28/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/17/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/26/2024
FIMP
FINAL DISPOSITION PROCESSED
12/26/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/17/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/16/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
07/16/2024
GPNX
NOTIFICATION PROCESSED BY IB
04/30/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/30/2024
PUBO
PUBLISHED FOR OPPOSITION
04/30/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/10/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/10/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/10/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/22/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/20/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/20/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/20/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/04/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/04/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/04/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/04/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/04/2024
RFNT
REFUSAL PROCESSED BY IB
11/07/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/17/2023
RFRR
REFUSAL PROCESSED BY MPU
10/17/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/30/2023
CNRT
NON-FINAL ACTION WRITTEN
09/29/2023
DOCK
ASSIGNED TO EXAMINER
09/26/2023
MAFR
APPLICATION FILING RECEIPT MAILED
02/28/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/24/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/23/2023
Continuous trademark protection
Get notified about every new filing that threatens DUOSPORE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.